NCT01187199 2026-04-16
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
16 trialsNCT01197170 2021-01-22
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00095459 2019-12-17
BAY 43-9006 (Sorafenib) and Bevacizumab (Avastin) To Treat Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00610246 2019-02-15
A Study of Radiation With Sorafenib in Advanced Cancer
University Health Network, Toronto
Phase 1 Completed
NCT02636426 2018-10-22
SOPRANO
Amsterdam UMC, location VUmc
Phase 1 Completed
NCT00811993 2016-11-02
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors
Hoffmann-La Roche
Phase 1 Terminated
NCT00627835 2016-07-20
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
British Columbia Cancer Agency
Phase 1 Withdrawn
NCT00941863 2016-03-22
Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)
Bayer
Phase 1 Completed
NCT01585870 2015-10-27
Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination
Bayer
Phase 1 Completed
NCT00259129 2014-11-13
Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients
Bayer
Phase 1 Completed
NCT00606125 2014-06-23
Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors
Bayer
Phase 1 Completed
NCT00562913 2013-11-26
Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin
Bayer
Phase 1 Completed
NCT01932177 2013-08-30
EVESOR
Hospices Civils de Lyon
Phase 1 Unknown
NCT00449280 2013-06-12
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
University of Chicago
Phase 1 Completed
NCT00562523 2013-05-23
Sorafenib/Docetaxel Dose Escalation Trial
Bayer
Phase 1 Completed
NCT00613145 2013-02-04
Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors
SCRI Development Innovations, LLC
Phase 1 Completed